MedTrace Logo

Testing a Reading Module to Improve Reading Skills and Quality of Life in Glaucoma Patients

NCT07741812 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-08-12

No results posted yet for this study

Summary

The goal of this interventional study is to test the effectiveness of reading rehabilitation module towards reading speed and error, and quality of life in glaucoma patients.The main questions it aims to answer are:

1. Is there a significant difference in reading speed over a 6-month period between glaucoma patients who undergo a reading rehabilitation module and those who receive standard care?
2. To what extent does the implementation of a reading rehabilitation module reduce the frequency of reading errors in glaucoma patients compared to a control group across baseline, 3-month, and 6-month follow-ups?
3. How does a structured reading rehabilitation module influence the self-reported quality of life in glaucoma patients from baseline to 6 months when compared to those receiving standard care?

Participants will:

Patients in interventional group will be instructed to practice the reading module for 20-30 minutes daily, minimum 3 days/week, for 6 months.

Visit the clinic once every 3 months for checkups and tests A logbook will be provided to record their practice sessions.

While participants in control group will receive standard care, visit the clinic once every 3 months for checkups and tests.

Conditions

  • Primary Open Angle Glaucoma (POAG)
  • Juvenile Open Angle Glaucoma
  • Normotensive Glaucoma
  • Primary Angle Closure Glaucoma

Interventions

OTHER

Reading Rehabilitation Module

Interventional group will be practicing reading rehabilitation module

Sponsors & Collaborators

  • Universiti Sains Malaysia

    lead OTHER

Principal Investigators

  • Mr. Mohd Bazlan Hafidz Mukrim Mohd Bazlan · Human Research Ethics Committee USM Division of Research & Innovation

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2027-02-28
Completion
2027-12-31

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07741812 on ClinicalTrials.gov